These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 9413212

  • 41. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK, Davey MW, Davey RA.
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [Abstract] [Full Text] [Related]

  • 42. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
    Horichi N, Tapiero H, Sugimoto Y, Bungo M, Nishiyama M, Fourcade A, Lampidis TJ, Kasahara K, Sasaki Y, Takahashi T.
    Cancer Res; 1990 Aug 01; 50(15):4698-701. PubMed ID: 2164445
    [Abstract] [Full Text] [Related]

  • 43. [The influence of sodium thiosulfate on the antitumor effect of cisplatin in human gastric cancer cell lines].
    Fujii T, Saito D, Yoshida S, Ookura H, Oguro Y.
    Gan To Kagaku Ryoho; 1988 Dec 01; 15(12):3227-32. PubMed ID: 3196041
    [Abstract] [Full Text] [Related]

  • 44. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
    Wang X, Kong L, Zhao J, Yang P.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul 01; 24(4):339-43. PubMed ID: 12408759
    [Abstract] [Full Text] [Related]

  • 45. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
    Polizzi D, Pratesi G, Tortoreto M, Supino R, Riva A, Bombardelli E, Zunino F.
    Cancer Res; 1999 Mar 01; 59(5):1036-40. PubMed ID: 10070960
    [Abstract] [Full Text] [Related]

  • 46. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD, Zhang LX, Yue W, Zhu YF, Lu HJ, Liu X, Cen XT, Guan XY, Li CH.
    Ai Zheng; 2003 Apr 01; 22(4):337-45. PubMed ID: 12703984
    [Abstract] [Full Text] [Related]

  • 47. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L, Liu J, Wang B, Gao M, Huang A.
    Oncol Rep; 2013 Feb 01; 29(2):555-62. PubMed ID: 23229111
    [Abstract] [Full Text] [Related]

  • 48. Epirubicin is equivalent to adriamycin in vitro against many cancer cells but more effective against gastric cancer cells.
    Kohnoe S, Yoshida M, Takahashi I, Emi Y, Maehara Y, Sugimachi K.
    Anticancer Res; 1992 Feb 01; 12(2):389-92. PubMed ID: 1580555
    [Abstract] [Full Text] [Related]

  • 49. Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines.
    Xu H, Choi SM, An CS, Min YD, Kim KC, Kim KJ, Choi CH.
    Biochem Biophys Res Commun; 2005 Mar 11; 328(2):618-22. PubMed ID: 15694393
    [Abstract] [Full Text] [Related]

  • 50. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
    Zhai BJ, Wu F, Shao ZY, Hu K, Zhao CL, Wang ZB.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb 11; 12(2):95-8. PubMed ID: 14980111
    [Abstract] [Full Text] [Related]

  • 51. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R, Tanabe K, Inoue H, Toge T.
    Int J Oncol; 2002 Mar 11; 20(3):549-55. PubMed ID: 11836567
    [Abstract] [Full Text] [Related]

  • 52. [Antitumor activity of the clavam peptide antibiotic G0069A].
    Xue YC, Chen WJ, Dai J, Qi CQ, Zhen YS.
    Yao Xue Xue Bao; 1997 Sep 11; 32(9):647-51. PubMed ID: 11596287
    [Abstract] [Full Text] [Related]

  • 53. Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cells.
    Osmak M, Brozović A, Ambriović-Ristov A, Hadzija M, Pivcević B, Smital T.
    Neoplasma; 1998 Sep 11; 45(4):223-30. PubMed ID: 9890665
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Toremifene sensitized the effect of adriamycin on human breast cancer cell lines].
    Nakagomi H, Furuya K, Hagiwara J, Nishio T, Watanabe K, Muto S, Takano K, Tada Y.
    Gan To Kagaku Ryoho; 1998 Apr 11; 25 Suppl 3():454-8. PubMed ID: 9589052
    [Abstract] [Full Text] [Related]

  • 58. Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
    Nishio K, Sugimoto Y, Nakagawa K, Niimi S, Fujiwara Y, Bungo M, Kasahara K, Fujiki H, Saijo N.
    Br J Cancer; 1990 Sep 11; 62(3):415-9. PubMed ID: 2206949
    [Abstract] [Full Text] [Related]

  • 59. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
    Yoshida M, Matsui Y, Ikarashi Y, Usui T, Osada H, Wakasugi H.
    Anticancer Res; 2007 Sep 11; 27(2):729-36. PubMed ID: 17465195
    [Abstract] [Full Text] [Related]

  • 60. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L, Wang C, Zheng W, Liu R, Yang J, Tang C.
    Anticancer Drugs; 2007 Oct 11; 18(9):1075-80. PubMed ID: 17704658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.